Neoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future Direction
- PMID: 27306709
Neoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future Direction
Abstract
Rectal cancer treatment presents a challenge, and its optimal management requires a multidisciplinary approach involving surgical, medical, and radiation oncologists. Advances in surgical techniques, radiotherapy, and medical imaging technology have transformed the therapeutic landscape and have led to substantial improvements in both local disease control and patient survival. The currently established standard of care for patients with locally advanced rectal cancer involves preoperative (neoadjuvant) concurrent radiotherapy and infusional fluorouracil-based or oral capecitabine-based chemotherapy, also known as chemoradiotherapy (CRT), followed by surgery. Surgery is often followed by adjuvant chemotherapy. Here we discuss the evolution of standard therapy for rectal cancer patients and the use of preoperative CRT for the treatment of locally advanced disease. Treatment schemes that have attempted to broaden the horizons of standard therapy include the use of induction chemotherapy and "watch-and-wait" approaches. We examine several novel trials using these and other treatment approaches, which may eventually lead to better patient selection and the avoidance of overtreatment and unnecessary adverse effects.
Comment in
-
It's Tough to Make Predictions, Especially About the Future ... of Rectal Cancer.Oncology (Williston Park). 2016 Jun;30(6):563-4. Oncology (Williston Park). 2016. PMID: 27306710 No abstract available.
Similar articles
-
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15. Lancet Oncol. 2015. PMID: 26189067 Clinical Trial.
-
Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape?Clin Colorectal Cancer. 2015 Dec;14(4):251-61. doi: 10.1016/j.clcc.2015.06.002. Epub 2015 Jun 17. Clin Colorectal Cancer. 2015. PMID: 26210575 Review.
-
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.J Clin Oncol. 2010 Feb 10;28(5):859-65. doi: 10.1200/JCO.2009.25.8541. Epub 2010 Jan 11. J Clin Oncol. 2010. PMID: 20065174 Clinical Trial.
-
Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer -- impact on long-term quality of life.Eur J Surg Oncol. 2012 Jun;38(6):472-7. doi: 10.1016/j.ejso.2012.02.002. Epub 2012 Feb 18. Eur J Surg Oncol. 2012. PMID: 22349986
-
Update on advances and controversy in rectal cancer treatment.Tech Coloproctol. 2016 Mar;20(3):145-52. doi: 10.1007/s10151-015-1418-y. Epub 2016 Jan 12. Tech Coloproctol. 2016. PMID: 26754651 Review.
Cited by
-
Unanticipated pathological clearance in two cases of clinical T4b dMMR/MSI-h advanced colorectal cancer: the potential of immune checkpoint inhibitors despite positive positron-emission tomography results.Surg Case Rep. 2024 May 1;10(1):105. doi: 10.1186/s40792-024-01894-x. Surg Case Rep. 2024. PMID: 38691233 Free PMC article.
-
Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.Eur Radiol. 2024 Jun;34(6):3686-3698. doi: 10.1007/s00330-023-10300-3. Epub 2023 Nov 23. Eur Radiol. 2024. PMID: 37994967
-
Effect of laparoscopic versus open surgery on postoperative wound complications in patients with low rectal cancer: A meta-analysis.Int Wound J. 2023 Nov 7;21(3):e14471. doi: 10.1111/iwj.14471. Online ahead of print. Int Wound J. 2023. PMID: 37935425 Free PMC article.
-
Neoadjuvant Therapy for Rectal Cancer.Surg Oncol Clin N Am. 2022 Apr;31(2):279-291. doi: 10.1016/j.soc.2021.11.008. Epub 2022 Mar 9. Surg Oncol Clin N Am. 2022. PMID: 35351278 Free PMC article. Review.
-
Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis.Front Oncol. 2021 May 12;11:642902. doi: 10.3389/fonc.2021.642902. eCollection 2021. Front Oncol. 2021. PMID: 34055611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials